Description
Book SynopsisThis book describes the growing clinical and healthcare relevance of nano-therapeutics in treating respiratory diseases. It begins with a brief introduction on the different types of nanoparticles in respiratory disease conditions. It further discusses the current trends in understanding the disease pathology using different in vitro and in vivo models, which are important towards the onsite clinical applications and development of new therapeutics. The book includes exciting topics such as formulation of these nanoparticles, targeting various organelles etc. It also describes the future prospects and challenges in the field. Different chapters are written by researchers actively working in the area of pulmonary diseases. This book is designed to address the requirements of both beginners and specialized scientists involved in pulmonary research. The contents include basic concepts followed by advanced state-of-art monitoring and treatment of diseases. The book is meant for researchers and industry experts in nanotechnology, pharmaceutical sciences and drug design.
Table of Contents1. Preface2. Introduction2.1. Nanotechnology and its influence2.2. Novel drug delivery systems2.3. Significance of nanomaterials in respiratory diseases3. Nanoparticles in chronic respiratory diseases3.1. Inflammatory respiratory diseases (Asthma, Chronic obstructive pulmonary disease, Tuberculosis, Lung cancer, Cystic fibrosis)3.2. Formulation and role of microparticles, microspheres, microemulsions in respiratory diseases3.3. Formulation and role of polymeric and inorganic nanoparticles3.4. Liposomes, niosomes, and dendrimers targeting in respiratory diseases3.5. Micelle targeting in respiratory diseases4. Targeting immune-system/ cellular level (macrophages & neutrophils) in respiratory diseases using advanced drug delivery systems5. Mucoadhesive drug delivery system in respiratory diseases6. Advancement in translational respiratory research using nanotechnology7. Nanotechnology in pulmonary disease diagnosis8. Clinical trials using in vitro and in vivo models9. Targeting biofilms in respiratory diseases using novel drug delivery systems10. Future prospects and challenges11. Bibliography12. Glossary
